CAS RN: 2183239-01-0
Varenicline-d4
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250701 |
1mg |
Out of stock |
5-7 business days | Inquiry |
-
Product code:
starshine_CAS2183239-01-0
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
2183239-01-0 / 13,13,15,15-tetradeuterio-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
Standard CAS: 2183239-01-0
Multi CAS: No
Basic Information
CAS
2183239-01-0
Multi CAS
No
Molecular Formula
C13H13N3
Molecular Weight
215.290000
Exact Mass
215.136054
SMILES
[2H]C1(C2CC(C3=CC4=NC=CN=C4C=C23)C(N1)([2H])[2H])[2H]
InChI
InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2/i6D2,7D2
InChIKey
JQSHBVHOMNKWFT-KXGHAPEVSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
10
Fraction Csp3
0.38
H-bond acceptors
3
H-bond donors
1
Molar refractivity
62.51
TPSA
37.81
LogP / Solubility
WLOGP
1.8
MLOGP
1.59
XLogP3
0.8
Consensus LogP
1.4
Log S (ESOL)
-2.75
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.59
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.53
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.73
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
5